(NP (NP (NP (NN Detection)) (PP (IN of) (NP (NP (JJ minimal) (JJ residual) (NN disease)) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (JJ acute) (JJ promyelocytic) (NN leukemia))))))) (PP (IN by) (NP (NN RT-PCR))) (: :)) (NP (NP (NN necessity)) (PP (IN of) (NP (NP (NN chemotherapy)) (PP-TMP (VBG following) (NP (NN ATRA) (NN therapy))))) (. .)))
(S (NP-SBJ (NP (DT The) (NN (RAR PML)) (NN alpha) (NN fusion) (NN gene)) (VP (VBG resulting) (PP (IN from) (NP (DT the) t (NN -LRB-15;17-RRB-) (NN translocation))))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ specific) (NN marker)) (PP (IN for) (NP (NP (JJ acute) (JJ promyelocytic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN APL)) (-RRB- -RRB-)))))) (. .))
(S (NP-SBJ-6 (PRP We)) (VP (VBD examined) (NP (NN bone) (NN marrow) (NNS cells)) (PP (IN by) (NP (NP (JJ reverse) (NN transcriptase-polymerase) (NN chain) (NN reaction)) (PRN (-LRB- -LRB-) (NP (NN RT-PCR)) (-RRB- -RRB-)))) (S (NP-SBJ (-NONE- *-6)) (VP (TO to) (VP (VB detect) (NP (NP (JJ residual) (ADJP (NN (RAR PML)) (NN alpha) (JJ mRNA-containing)) (NNS cells)) (PP-TMP (VBG following) (NP-COOD (NP (NP (NN treatment)) (PP (IN with) (NP (NP (JJ all-trans) (JJ retinoic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN ATRA)) (-RRB- -RRB-))))) (CC and) (NP (JJ cytotoxic) (NN chemotherapy))))) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NN APL))))))))) (. .))
(S (NP-SBJ (DT This) (NN RT-PCR) (NN assay)) (VP (MD can) (VP (VB detect) (NP (CD one) (JJ leukemic) (NN cell)) (PP (IN in) (NP (CD 10-LRB-2-RRB-) (JJ normal) (NNS cells))) (ADVP (FW in) (FW vitro)))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ (NN (RAR PML)) (NN alpha) (NN mRNA)) (VP-COOD (VP (VBD was) (ADVP (RB still)) (ADJP-PRD-101 (JJ detectable)) (PP-102 (IN despite) (NP (NP (JJ clinical) (NN remission)) (PP-TMP (VBG following) (NP (NN ATRA) (NN treatment)))))) (, ,) (CC but) (VP (ADJP-PRD=101 (JJ undetectable)) (PP-TMP (VBG following) (NP (NP (NN consolidation)) (PP (IN with) (NP (NN chemotherapy)))))))))) (. .))
(S (NP-SBJ (DT These) (NNS data)) (VP (VBP show) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (DT this) (NN technique)) (VP (VBZ is) (ADJP-PRD (JJ useful) (PP (IN for) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (JJ minimal) (JJ residual) (NN disease)) (PP (NN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN APL))))))))))))) (CC and) (SBAR (IN that) (S (NP-SBJ-7 (NP (JJ cytotoxic) (NN chemotherapy)) (PP-TMP (VBG following) (NP (NN ATRA) (NN therapy)))) (VP (VBZ is) (VP (VBN required) (NP (-NONE- *-7)) (PP (IN for) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (NN APL) (NNS cells))))))))))) (. .))
